Inventor

Ming-Shi Chang

Inventor
Tainan, TW

Overview

39→
Patents
1994–2018
Patent span
Human necessities
Primary field (CPC A)

Patents· 39 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides29%
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A01KAnimal husbandry11%
C12NMicroorganisms or enzymes5%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
LOC301%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%
PatentTitleYear
9,982,043Use of IL-20 antagonists for treating pancreatic cancer20189,758,575'Antibodies which specifically bind to canine vascular endothelial growth factor and uses thereof'20179,751,949'Method of inhibiting adipogenesis with an IL-20 antibody'20179,683,036'Humanized anti-IL-20 antibody and uses thereof'20179,512,218'Use of IL-20 antagonists for alleviating spinal cord injury'20169,376,490'Treatment of inflammatory pain using IL-20 antagonists'20169,365,652'Use of IL-20 antagonists for treating liver diseases'20169,221,904'Treatment of osteoarthritis using IL-20 antagonists'20159,217,031'Humanized anti-IL-20 antibody and uses thereof'20159,127,066'Methods for treating osteoporosis with anti-IL-20 receptor antibodies'20158,911,730'Methods of using antibodies to block human thymic stromal lymphopoietin (TSLP) receptor activity'20148,852,588'Treating allergic airway disorders using anti-IL-20 receptor antibodies'20148,603,470'Use of IL-20 antagonists for treating liver diseases'20138,597,647'Humanized anti-IL-20 antibody and uses thereof'20138,535,674'Treating breast cancer and inhibiting cancer-associated bone loss with anti-IL-20 antibody'20138,454,956'Methods for treating rheumatoid arthritis and osteoporosis with anti-IL-20 antibodies'20138,377,441'Treating breast cancer with anti-IL-19 antibody'20138,344,110'Antibodies to thymic stromal lymphopoietin (TSLP) receptor molecules and uses thereof'20138,206,712'Use of anti-IL-20 antibody for treating rheumatoid arthritis'20128,012,478'Use of anti-IL-20 antibody for treating stroke'20117,964,713'Nucleic acid molecules encoding thymic stromal lympopoietin receptor proteins and a process for producing the encoded polypeptides thereof'20117,837,994'Use of anti-IL-20 antibody for treating osteoporosis'20107,786,274'Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases'20107,632,922'Osteoprotegerin'20097,611,705'Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases'20097,435,800'Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation'20087,005,413'Combination therapy for conditions leading to bone loss'2006D0494716'Treat dispensing toy'20046,613,544'Osteoprotegerin'20036,369,027'Osteoprotegerin'20026,288,032'Osteoprotegerin'20016,284,728'Osteoprotegerin'20016,284,740'Osteoprotegerin'20016,284,485'Nucleic acids encoding osteoprotegerin'20016,143,874'Antibodies to the neurotrophic factor NNT-1'20006,054,294'Nucleic acid molecules encoding the neurotrophic factor NNT-1'20006,015,938'Osteoprotegerin'20005,741,772'Neurotrophic factor NNT-1'19985,352,587'Compositions and methods for the synthesis of natriuretic protein receptor B and methods of use'1994

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1994Patents assigned to GENENTECH INC (1)· patent assignee history
1994–2013Based in Newbury Park, CA, US· patent location history
1998–2014Patents assigned to AMGEN INC (15)· patent assignee history
2004Based in Burr Ridge, IL, US· patent location history
2006–2018Based in Tainan, TW· patent location history
2008Patents assigned to CHI MEI MEDICAL CT (1)· patent assignee history
2009–2018Patents assigned to UNIV NAT CHENG KUNG (20)· patent assignee history
2012–2015Patents assigned to CHANG MING-SHI (9)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV NAT CHENG KUNG202009–2018
AMGEN INC151998–2014
CHANG MING-SHIself92012–2015
CHI MEI MEDICAL CT12008
GENENTECH INC11994
Locations
LocationPatentsSpan
Tainan, TW252006–2018
Newbury Park, California, US131994–2013
Burr Ridge, Illinois, US12004